Latest filing published 02 Dec 2019 for Inhibitor Therapeutics, Inc., €858.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -27.3%Entry US$0.05 · Close at T+365 US$0.04
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Garrison J. Hasara: trading record in brief
This profile gathers the share dealings of Garrison J. Hasara in Inhibitor Therapeutics, Inc. In total, 6 filings cover trades dated from 8 March 2017 to 2 December 2019.
Both buying and selling appear: 1 purchase worth €858, against 1 sale worth €23k. Taken together, the sales exceed the purchases by €22k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 share grants and 2 option exercises. 2019 to date brings 1 purchase and no sales.
The record was last updated on 2 December 2019 with an open-market purchase (€858) in Inhibitor Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Garrison J. Hasara
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,500 shares@ US$0.073.6% of flowCommon StockSEC:0000899243-19-028374:0Canonical exit: 1 Mar 2020 (T+90)
- 100,000 shares@ US$0.2796.4% of flowCommon StockSEC:0000899243-18-023650:0
- 1,470,478 shares@ US$0.3495.2% of flowCommon StockSEC:0000899243-17-007153:1
- 3,500,000 sharesCommon StockSEC:0000899243-17-007153:0
- 3,500,000 sharesCommon StockSEC:0000899243-17-007153:2
5 of 5 declarations